SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-029259
Filing Date
2016-11-14
Accepted
2016-11-14 16:31:04
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20160930.htm 10-Q 1469070
2 EX-31.1 abio-ex311_7.htm EX-31.1 8581
3 EX-31.2 abio-ex312_6.htm EX-31.2 8539
4 EX-32.1 abio-ex321_8.htm EX-32.1 11244
  Complete submission text file 0001564590-16-029259.txt   4780680

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20160930.xml EX-101.INS 969532
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20160930.xsd EX-101.SCH 36562
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20160930_cal.xml EX-101.CAL 35965
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20160930_def.xml EX-101.DEF 93211
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20160930_lab.xml EX-101.LAB 294294
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20160930_pre.xml EX-101.PRE 212508
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 161995172
SIC: 2835 In Vitro & In Vivo Diagnostic Substances